Episode
CareDx CEO Executes Planned Stock Sale
- Published
- Jun 22, 2026
- Duration seconds
- 94
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/business-finance-news-today-2-min-news-the-daily-news-now-7726192/episodes/caredx-ceo-executes-planned-stock-sale/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/business-finance-news-today-2-min-news-the-daily-news-now-7726192/caredx-ceo-executes-planned-stock-sale.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
John Hanna, CEO of CareDx, quietly cashed out nearly 17,700 shares worth $425K in a pre-planned move under Rule 10b5-1, part of a consistent quarterly selling strategy since April — all while still holding over 631K shares. The transplant diagnostics firm continues its mission to revolutionize post-transplant care, even as its stock lags broader markets. This isn’t panic — it’s precision finance. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: [email protected] This is an automated, high-level news summary based on public reporting. Report issues to [email protected]. View sources & latest updates: https://sources.thednn.ai/b64646491f1bd066